TY - JOUR
T1 - Estimating Australian Hospitalization Ratios and Costs for Wildtype SARS-CoV-2 in 2020
AU - Markey, Peter
AU - Bayliss, Julianne
AU - Jones, Daryl
AU - Trauer, James
AU - Pilcher, David
AU - Ademi, Zanfina
N1 - Funding Information:
The authors wish to acknowledge the data generously provided for this study by: Victorian Department of Health - Public Health Event Surveillance System, Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resource Evaluation – Adult and Pediatric Databases. The authors and the ANZICS CORE management committee would like to thank clinicians, data collectors and researchers at the contributing sites. Alfred Hospital – Patient Administration and Cost Database.
Publisher Copyright:
© 2023 The Authors
PY - 2023/11
Y1 - 2023/11
N2 - Utilizing a retrospective cohort study of SARS-CoV-2 wildtype (Wuhan) strain, we aimed to 1) utilize the unique Australian experience of temporarily eliminating SARS-CoV-2 to document and estimate the hospitalization demand; and 2) estimate the inpatient hospital costs associated with treatment. Case data was based on Victoria Australia from March 29 to December 31, 2020. Outcomes measures included hospitalization demand and case fatality ratio and inpatient hospitalization costs. Population adjusted results indicated that 10.2% (CI 9.9%-10.5%) required ward only admission, 1.0% (CI 0.9%-1.1%) required ICU admission plus 1.0% (CI 0.9%-1.1%) required ICU with mechanical ventilation. The overall case fatality ratio was 2.9% (CI 2.7%-3.1%). Mean ward only patient costs ranged from $22,714 to $57,100 per admission whilst ICU patient costs ranged from $37,228 to $140,455. With delayed, manageable outbreaks and public health measures leading to temporary elimination of community transmission, the Victorian COVID-19 data provides insight into initial pandemic severity and hospital costs.
AB - Utilizing a retrospective cohort study of SARS-CoV-2 wildtype (Wuhan) strain, we aimed to 1) utilize the unique Australian experience of temporarily eliminating SARS-CoV-2 to document and estimate the hospitalization demand; and 2) estimate the inpatient hospital costs associated with treatment. Case data was based on Victoria Australia from March 29 to December 31, 2020. Outcomes measures included hospitalization demand and case fatality ratio and inpatient hospitalization costs. Population adjusted results indicated that 10.2% (CI 9.9%-10.5%) required ward only admission, 1.0% (CI 0.9%-1.1%) required ICU admission plus 1.0% (CI 0.9%-1.1%) required ICU with mechanical ventilation. The overall case fatality ratio was 2.9% (CI 2.7%-3.1%). Mean ward only patient costs ranged from $22,714 to $57,100 per admission whilst ICU patient costs ranged from $37,228 to $140,455. With delayed, manageable outbreaks and public health measures leading to temporary elimination of community transmission, the Victorian COVID-19 data provides insight into initial pandemic severity and hospital costs.
UR - http://www.scopus.com/inward/record.url?scp=85165109891&partnerID=8YFLogxK
U2 - 10.1016/j.cpcardiol.2023.101917
DO - 10.1016/j.cpcardiol.2023.101917
M3 - Review Article
C2 - 37394203
AN - SCOPUS:85165109891
SN - 0146-2806
VL - 48
JO - Current Problems in Cardiology
JF - Current Problems in Cardiology
IS - 11
M1 - 101917
ER -
